5 Ways Express Scripts is Reining in Rx Prices

Feb 22, 2018
Focused on actionable data insights and specialized clinical care, Express Scripts’ experts share perspective on key healthcare topics this month.
Kyle Shayna Article

Express Scripts’ experts share key insights on key healthcare topics right now. Here are our top five articles from this month:

1. Record-Low Increase in Rx Spending in 2017

In 2017, as the nation debated ways to rein in drug prices, Express Scripts did just that: We achieved record-low drug trend – the year-over-year change in drug spending – across our commercial, Medicare, Medicaid and health insurance exchange lines of business.

2. Express Scripts 2017 Public Policy Analysis

Even with high drug prices in the public eye, lawmakers have yet to coalesce around legislation to address the issue. Express Scripts has outlined viable, cost-saving policy ideas for public and private payers. Read about three areas of policy focus that are ripe for legislative and/or regulatory attention.

3. White House Budget is Positive for Patients, Plans and PBMs

America has too many examples of irrational drug prices. A recent white paper released from the Council of Economic Advisors reviews policy options to lower prescription drug costs.

4. FDA Update: February 2018

Express Scripts’ Emerging Therapeutics team monitors new drug approvals, new generics and other actions from the U.S. Food and Drug Administration (FDA). Read about some important approvals and updates we tracked over the past month.

5. Changing the Way We Fight the Opioid Epidemic

Through Advanced Opioid ManagementSM, Express Scripts is working with clients to protect their members and their families, and early results demonstrate its working: Together with our clients, we are curbing opioid misuse with 60% lower average day supply per claim (down from 18.6 days to 7.5). We also influenced 95.9% of reprocessed scripts to be 7 days’ supply or less.

Author Bio

Lab Staff
comments powered by Disqus